PIBT - biotherapies innovation cluster
Accredited as a Biotherapies & Bioproduction Integrator in May 2023, the PIBT’s ambition is to drive
innovation by rallying the stakeholders and skills needed to carry out every project, such as:
- The RIGHT and CTM laboratories
- Breakthrough engineering in FC’INNOV, the result of FEMTO-ST research, helps to remove the technological barriers to current production processes
- University hospitals and treatment centres to identify clinical needs and guide and approve therapeutic strategies
Research laboratories*
SUPERVISORY INSTITUTIONS: EFS BFC, INSERM, uMLP
New treatments that modulate the immune system to prevent it from going into overdrive or rejecting a transplant, or making it more capable of eliminating a tumour
umr-right.com
SUPERVISORY INSTITUTIONS: UBE, INSERM, Institut AGRO Dijon
Translational research centre in Molecular Medicine working on various themes: therapies and immune response in cancer, epigenetics, TNF receptors, etc.
ctm.ube.fr
SUPERVISORY INSTITUTIONS: UBE, CNRS
Intelligent imaging probes, multimodal imaging technologies, theranostic agents and internal vectorised radiotherapy, for applications in oncology in particular
icmub.ube.fr
SUPERVISORY INSTITUTIONS: uMLP, UTBM, Besançon University Hospital
Integrated care, healthcare engineering, new theranostics approaches & nanotechnologies, biomarkers, artificial intelligence, etc.
lab-sinergies.fr
SUPERVISORY INSTITUTIONS: CNRS, uMLP, SUPmicrotech-ENSMM, UTBM
Physiological microsystems, microfluidics, microrobotics for manipulating biological objects, biosensors, biofunctionalised surfaces, vision, artificial intelligence, organs-on-a-chip, extracellular vesicles and characterisation at micro and nanometric scales
femto-st.fr/en
SUPERVISORY INSTITUTION: UBE
Imaging and Artificial Vision: vision systems, real-time image analysis, AI for signal and image analysis, multi-modal imaging systems, robotic control, etc.
imvia.ube.fr
SUPERVISORY INSTITUTIONS: UTBM, UBE
Research and innovation in artificial intelligence to design the AI of tomorrow
ciad-lab.fr
SUPERVISORY INSTITUTIONS: UBE, CNRS
CO-SUPERVISORY INSTITUTION: UTBM
Advanced technologies for innovative therapies, theranostics & intelligent bioproduction: manufacture of microsystems integrating photonics, micro-fluidics, mechanics and automation; nanosensors and biosensors; nano-vectorisation and nano-functionalisation; nanoparticle elaboration; enzymology and bioproduction; digital twins; modelling of biological systems
icb.cnrs.fr
SUPERVISORY INSTITUTIONS: uMLP, CNRS
Development of biomaterials based on coordination complexes with anticancer/antidiabetic activity or conductive polymers derived from antibacterial ionic liquids
utinam.cnrs.fr
SUPERVISORY INSTITUTIONS: UBE, Institut AGRO Dijon, INRAE
Processes for culturing, stabilising and shaping human commensal probiotics, including anaerobes
umr-pam.fr
*Non-exhaustive list
Treatment centres & clinical trials*
Immunity, metabolism, inflammation, eye-heart-brain interactions, integrative approach to care in oncology, haematology and rare diseases: from genomics to therapeutic innovations
chu-dijon.fr / chu-dijon.fr/centre-dinvestigation-clinique
Development and evaluation of biotherapies in oncology and haematology, transplantation, tissue and organ grafts, inflammatory diseases, etc.
chu-besancon.fr / chu-besancon.fr/centre-dinvestigation-clinique
Hospital and research centre for cancer, personalised medicine, molecular imaging, internal vectorised radiotherapy, etc.
cgfl.fr
France’s leading supplier of cells and tissues for transplants
Leading producer of advanced therapy drugs for phase I and II clinical trials
efs.sante.fr
*Non-exhaustive list
Other organisations
CLIP2 – Accredited centre for early phases
This accreditation is awarded by the French National Cancer Institute. In the region, it has been awarded to the Early Stage Unit (U2P) at the Georges-François Leclerc Centre, the Besançon University Hospital (Immuno-Oncology) and the Dijon University Hospital (Clinical Haematology)
The Pôle Universitaire d’Innovation Bourgogne-Franche-Comté (PUI BFC – BFC university innovation cluster)
The PUI BFC aims to capitalise on the results of academic research and to support entrepreneurship and deep-tech start-ups through its ‘Health, diagnostics and connected biotherapies’ strategic hub
Supporting, structuring and promoting cancer research in Bourgogne-Franche-Comté and the Grand Est region
canceropole-est.org